A Chinese scientist is dismissed following the death of a child in an experimental gene-editing trial, according to multiple reports. The death occurs after the child receives gene therapy aimed at changing a genetic condition, prompting an investigation and institutional actions.

CBS News and The Hindu both describe the death and the broader finding that an investigation is involved, but they differ in the specific medical framing. CBS News says the therapy targeted a condition described as non-life-threatening, while The Hindu, citing state media, identifies the condition as Snijders Blok-Campeau syndrome, a rare neurodevelopmental disorder.

Nature reports the scientist is sacked and adds that other institutions and researchers connected to the work are also reprimanded. Across outlets, the central points remain consistent: the trial involved gene editing, a child died after receiving the experimental therapy, and the response includes termination and reprimands within the research ecosystem, alongside references to investigation findings.